Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
Transcatheter aortic valve implantation (TAVI) via femoral arterial access has become the treatment of choice for elderly patients with severe calcific aortic stenosis (AS) who are at intermediate or high risk for surgical aortic valve replacement (SAVR).1,2 More recently, randomised trials have led to the approval of TAVI for patients at lower surgical risk, thereby expanding its applicabil...
Source: Radcliffe Cardiology - Category: Cardiology Authors: c242508f1d9059bc0f2aa9bdd5421ba2 Source Type: research
More News: Aortic Stenosis | Cardiology | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves